These are questions that local biotechnology companies have to think about and answer every day. One local entrepreneur scientists, J. Roberto Trujillo, President & CEO, TruBios, LLC, is working diligently to answer these tough questions as he sets a lofty goal for his company and its affiliates and subsidiaries: to eradicate all viral diseases in the Americas within the next 38 years. He and his colleagues call this goal Project 2050. One of the first diseases they’re targeting is cervical cancer.
According to Trujillo, 80% of cervical cancer cases can be found in developing countries where the resources needed to treat these kinds of diseases are scarce.
“How can you diagnose someone and then not treat them?” Trujillo asked. “Why even diagnose them in the first place?”
Trujillo recently struck up a collaboration with Dr. Vanderlei Bagnato from the University of Sao Paulo, Brazil, to launch a new company, CERCA Solutions, which is devoted to diagnosing and treating cervical cancer through a technology called Photodynamic Therapy (PDT). This technology already is being used to treat esophageal, colon, and skin cancers.